Copyright (c) 2009 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=cgenLatest Financial News for Compugen Ltd.en-usThu, 24 Dec 2009 14:28:28 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=134mr0dmj/*http%3A//seekingalpha.com/article/179775-compugen-pfizer-deal-what-biotech-dreamers-can-accomplish?source=yahooyahoo_finance/1695264208Thu, 24 Dec 2009 14:28:28 Etc/GMThttp://us.rd.yahoo.com/finance/external/barrons/rss/SIG=11v577tks/*http%3A//online.barrons.com/article/SB126152060280202043.html?ru=yahoo&mod=yahoobarronsStocks in the Spotlight Wednesday Cintas fell. Compugen, Achillion and pSivida all rose.yahoo_finance/1450573989Wed, 23 Dec 2009 21:57:45 Etc/GMThttp://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh81715_2009-12-23_18-13-50_sge5bm0iy_newsml&rpc=44&type=marketsNewsyahoo_finance/6519240Wed, 23 Dec 2009 18:13:50 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12m0527d3/*http%3A//www.marketwatch.com/news/story/israel-stocks-mixed-compugen-deal/story.aspx?guid=%7B8BE9F9A5%2D5D3F%2D4C59%2DA8D1%2DA4A9F9F1E345%7D&siteid=yhoofIsraeli stocks were mixed to higher on Wednesday, as strength in Teva Pharmaceutical, the banks and the technology stocks was offset by weakness in Israel Chemicals and its parent.yahoo_finance/2802761338Wed, 23 Dec 2009 14:45:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091223/20091223005105.html?.v=1TEL AVIV, Israel----Compugen Ltd. announced today that it has signed a collaboration agreement with Pfizer for the predictive discovery by Compugen of therapeutic peptide product candidates for three drug targets of interest to Pfizer.yahoo_finance/654771616Wed, 23 Dec 2009 12:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091109/20091109005696.html?.v=1TEL AVIV, Israel----Compugen Ltd. announced today the discovery and experimental confirmation of a genetic biomarker, CGEN-40001 for predisposition to type 2 diabetes, the most common form of diabetes.yahoo_finance/69162945Mon, 9 Nov 2009 12:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091105/20091105005613.html?.v=1TEL AVIV, Israel----Compugen Ltd. announced today that it has signed a research and license agreement with a leading diagnostic company covering CGEN-226, a novel biomarker candidate for early detection of preeclampsia.yahoo_finance/3407425368Thu, 5 Nov 2009 12:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/cc/3/108773.htmlyahoo_finance/548039508Tue, 27 Oct 2009 14:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/research/earncal/20091027.html?t=cgenyahoo_finance/1421203386Tue, 27 Oct 2009 11:07:30 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091027/20091027005588.html?.v=1TEL AVIV, Israel----Compugen Ltd. today reported financial results for the third quarter ended September 30, 2009.yahoo_finance/2946116433Tue, 27 Oct 2009 11:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091026/20091026005535.html?.v=1TEL AVIV, Israel & BARCELONA, Spain----Speaking today in Barcelona at the Fifth Peptide Engineering Meeting, Compugen Ltd. project manager Dr. Yossef Kliger provided an overview of Compugen’s DAC Blockers Platform and reviewed disease model data for selected product candidates.yahoo_finance/2261426495Mon, 26 Oct 2009 11:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091020/20091020005733.html?.v=1TEL AVIV, Israel----Compugen Ltd. today announced that the Company plans to host a live conference call and webcast at 10:00 AM EDT on Tuesday, October 27, 2009 to review third quarter 2009 results.yahoo_finance/560721255Tue, 20 Oct 2009 11:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091013/20091013005579.html?.v=1TEL AVIV, Israel----Compugen Ltd. announced today that they have signed a collaboration agreement with Bayer Schering Pharma AG, Germany covering the further evaluation of a Compugen discovered tumor target and its splice variants.yahoo_finance/635024179Tue, 13 Oct 2009 11:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=cgen&annualyahoo_finance/666104074Tue, 18 Aug 2009 13:04:39 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/cc/4/106234.htmlyahoo_finance/3783780035Tue, 28 Jul 2009 14:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmpe/rss/SIG=128feis9t/*http://www.thestreet.com/p/_yahoo/rmoney/pharmaceuticals/10492283.html?cm_ven=YAHOO&cm_cat=PREMIUM&cm_ite=003190yahoo_finance/2737526332Mon, 27 Apr 2009 14:58:49 Etc/GMT